Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Benitec Biopharma (BNTC) EBT Margin (2019 - 2023)

Historic EBT Margin for Benitec Biopharma (BNTC) over the last 5 years, with Q2 2023 value amounting to 65114.29%.

  • Benitec Biopharma's EBT Margin changed N/A to 65114.29% in Q2 2023 from the same period last year, while for Mar 2024 it was 307371.43%, marking a year-over-year decrease of 2789831900.0%. This contributed to the annual value of 25485.33% for FY2023, which is 9839600.0% down from last year.
  • As of Q2 2023, Benitec Biopharma's EBT Margin stood at 65114.29%.
  • Over the past 5 years, Benitec Biopharma's EBT Margin peaked at 8220.0% during Q2 2020, and registered a low of 379500.0% during Q1 2021.
  • Moreover, its 5-year median value for EBT Margin was 8051.85% (2023), whereas its average is 80666.78%.
  • Per our database at Business Quant, Benitec Biopharma's EBT Margin tumbled by 2000000000bps in 2021 and then soared by 2000000000bps in 2022.
  • Quarter analysis of 5 years shows Benitec Biopharma's EBT Margin stood at 2719.48% in 2019, then crashed by -11891bps to 326100.0% in 2020, then surged by 94bps to 19384.0% in 2021, then crashed by -107bps to 40135.71% in 2022, then plummeted by -62bps to 65114.29% in 2023.
  • Its EBT Margin was 65114.29% in Q2 2023, compared to 8051.85% in Q1 2023 and 40135.71% in Q4 2022.